Causeway Capital Management LLC Trimmed Holding in Lilly Eli & Co (LLY) as Share Value Declined

February 15, 2018 - By Michael Collier

Investors sentiment decreased to 0.89 in Q3 2017. Its down 0.01, from 0.9 in 2017Q2. It worsened, as 66 investors sold LLY shares while 386 reduced holdings. 79 funds opened positions while 325 raised stakes. 827.83 million shares or 0.59% more from 823.00 million shares in 2017Q2 were reported. Gateway Investment Advisers Limited Liability reported 568,671 shares. Sun Life Financial has invested 0.06% of its portfolio in Eli Lilly and Company (NYSE:LLY). Utd Automobile Association reported 493,952 shares. Pdts Llc has 0.77% invested in Eli Lilly and Company (NYSE:LLY) for 272,900 shares. Notis holds 3,000 shares. Boston Private Wealth Limited Liability Com owns 23,261 shares. Minnesota-based Palisade Asset Management Limited Company has invested 0.34% in Eli Lilly and Company (NYSE:LLY). Brinker has 50,125 shares for 0.18% of their portfolio. Bahl & Gaynor Inc holds 28,917 shares or 0.03% of its portfolio. Tcw Gru Inc holds 0.03% in Eli Lilly and Company (NYSE:LLY) or 37,865 shares. Edge Wealth Mngmt Ltd accumulated 560 shares. Dearborn Ltd Com accumulated 3,270 shares. Vanguard Group invested 0.29% in Eli Lilly and Company (NYSE:LLY). Perigon Wealth Mngmt Ltd Liability Corp stated it has 2,366 shares or 0.07% of all its holdings. Rmsincerbeaux Capital Mgmt Limited Liability Corp has 6,200 shares for 0.51% of their portfolio.

Since August 31, 2017, it had 0 insider buys, and 8 sales for $84.24 million activity. $72,981 worth of Eli Lilly and Company (NYSE:LLY) was sold by Zakrowski Donald A. 9,625 shares valued at $780,780 were sold by Simmons Jeffrey N on Thursday, February 1.

Causeway Capital Management Llc decreased its stake in Lilly Eli & Co (LLY) by 7.99% based on its latest 2017Q3 regulatory filing with the SEC. Causeway Capital Management Llc sold 261,293 shares as the company’s stock declined 3.22% while stock markets rallied. The institutional investor held 3.01 million shares of the major pharmaceuticals company at the end of 2017Q3, valued at $257.30M, down from 3.27 million at the end of the previous reported quarter. Causeway Capital Management Llc who had been investing in Lilly Eli & Co for a number of months, seems to be less bullish one the $81.67B market cap company. The stock increased 1.25% or $0.9606 during the last trading session, reaching $77.9906. About 1.88 million shares traded. Eli Lilly and Company (NYSE:LLY) has risen 4.70% since February 15, 2017 and is uptrending. It has underperformed by 12.00% the S&P500.

Causeway Capital Management Llc, which manages about $27.14B and $8.90B US Long portfolio, upped its stake in Icici Bk Ltd (NYSE:IBN) by 1.22M shares to 7.15 million shares, valued at $61.22M in 2017Q3, according to the filing. It also increased its holding in Vanguard Intl Equity Index F (VWO) by 630,439 shares in the quarter, for a total of 2.08M shares, and has risen its stake in British Amern Tob Plc (NYSEMKT:BTI).

More notable recent Eli Lilly and Company (NYSE:LLY) news were published by: which released: “Earnings Reaction History: Eli Lilly & Co., 36.4% Follow-Through Indicator, 1 …” on January 31, 2018, also with their article: “Why Eli Lilly and Co Stock is Taking a Hit Today” published on January 31, 2018, published: “Eli Lilly & Co. (LLY) Phase 3 Study for Taltz in Ankylosing Spondylitis Met …” on February 13, 2018. More interesting news about Eli Lilly and Company (NYSE:LLY) were released by: and their article: “Eli Lilly And Co. Profit Rises In Q4” published on January 31, 2018 as well as‘s news article titled: “The case for Johnson & Johnson” with publication date: February 13, 2018.

Eli Lilly and Company (NYSE:LLY) Ratings Coverage

Among 20 analysts covering Eli Lilly and Company (NYSE:LLY), 11 have Buy rating, 2 Sell and 7 Hold. Therefore 55% are positive. Eli Lilly and Company had 95 analyst reports since July 23, 2015 according to SRatingsIntel. As per Friday, October 27, the company rating was maintained by SunTrust. Jefferies maintained the stock with “Buy” rating in Tuesday, March 15 report. Berenberg initiated Eli Lilly and Company (NYSE:LLY) rating on Thursday, August 27. Berenberg has “Buy” rating and $100 target. The stock of Eli Lilly and Company (NYSE:LLY) earned “Buy” rating by Jefferies on Monday, June 5. The stock of Eli Lilly and Company (NYSE:LLY) has “Buy” rating given on Tuesday, October 3 by Cowen & Co. The rating was maintained by Barclays Capital on Friday, April 7 with “Overweight”. Jefferies maintained Eli Lilly and Company (NYSE:LLY) on Friday, June 16 with “Buy” rating. The firm has “Overweight” rating given on Thursday, September 8 by JP Morgan. The firm has “Equal-Weight” rating given on Tuesday, November 21 by Morgan Stanley. The rating was maintained by Piper Jaffray with “Buy” on Thursday, October 12.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.